loading...| Preferred Name | Icosapent Ethyl | |
| Synonyms |
Ethyl Icosapentate (all-Z)-5,8,11,14,17-Eicosapentaenoic Acid Ethyl Ester Ethyl (all cis)-5,8,11,14,17-icosapentaenoate ICOSAPENT ETHYL Cis-Eicosapentaenoic Acid Ethyl Ester Icosapent Ethyl AMR 101 AMR101 Vascepa |
|
| Definitions |
A highly purified omega-3 fatty acid that can decrease serum triglyceride levels. Icosapent ethyl reduces serum triglycerides without an increase in LDL cholesterol, but increases the cholesterol and triglyceride content in skeletal muscle. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C72986 |
|
| Accepted_Therapeutic_Use_For |
Treatment of hypertriglyceridemia |
|
| CAS_Registry |
73310-10-8 |
|
| Chemical_Formula |
C22H34O2 |
|
| code |
C72986 |
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173381 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173383 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 |
|
| Contributing_Source |
CTRP FDA |
|
| DEFINITION |
A highly purified omega-3 fatty acid that can decrease serum triglyceride levels. Icosapent ethyl reduces serum triglycerides without an increase in LDL cholesterol, but increases the cholesterol and triglyceride content in skeletal muscle. |
|
| Display_Name |
Icosapent Ethyl |
|
| FDA_UNII_Code |
6GC8A4PAYH |
|
| FULL_SYN |
Ethyl Icosapentate (all-Z)-5,8,11,14,17-Eicosapentaenoic Acid Ethyl Ester Ethyl (all cis)-5,8,11,14,17-icosapentaenoate ICOSAPENT ETHYL Cis-Eicosapentaenoic Acid Ethyl Ester Icosapent Ethyl AMR 101 AMR101 Vascepa |
|
| label |
Icosapent Ethyl |
|
| Legacy Concept Name |
Ethyl_Icosapentate |
|
| NCI_Drug_Dictionary_ID |
785885 |
|
| PDQ_Closed_Trial_Search_ID |
785885 |
|
| PDQ_Open_Trial_Search_ID |
785885 |
|
| Preferred_Name |
Icosapent Ethyl |
|
| prefixIRI |
Thesaurus:C72986 |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C3486026 |
|
| subClassOf |